Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis
Sponsor: AstraZeneca
Summary
The Polish multicentre observational (non-interventional) study aiming to collect data on the management and clinical outcomes of patients with gMG that received ravulizumab.
Official title: Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis (gMG) Naive to Complement Inhibitors. Prospective, Multicenter, Non-interventional Study (MG-ARCADIA).
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2025-05-15
Completion Date
2029-12-31
Last Updated
2026-03-13
Healthy Volunteers
No
Conditions
Interventions
Ravulizumab
Ravulizumab, concentrate for solution for infusion
Locations (14)
Research Site
Bydgoszcz, Poland
Research Site
Gdansk, Poland
Research Site
Katowice, Poland
Research Site
Katowice, Poland
Research Site
Krakow, Poland
Research Site
Lodz, Poland
Research Site
Lublin, Poland
Research Site
Poznan, Poland
Research Site
Poznan, Poland
Research Site
Szczecin, Poland
Research Site
Szczecin, Poland
Research Site
Warsaw, Poland
Research Site
Warsaw, Poland
Research Site
Wroclaw, Poland